ArticleTranslational oncology2026
CXCL11 recruits immunosuppressive cells to form a barrier at the invasive front of pancreatic cancer by activating the NF-κB/CCL2 axis.
Fang Wei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.